Encompass Health Corporation $EHC Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp lessened its stake in Encompass Health Corporation (NYSE:EHC) by 12.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 886,331 shares of the company’s stock after selling 124,848 shares during the quarter. Bank of New York Mellon Corp’s holdings in Encompass Health were worth $94,075,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Goldman Sachs Group Inc. increased its stake in Encompass Health by 35.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 451,804 shares of the company’s stock worth $47,954,000 after buying an additional 119,145 shares in the last quarter. AXQ Capital LP lifted its stake in Encompass Health by 416.2% during the fourth quarter. AXQ Capital LP now owns 15,495 shares of the company’s stock worth $1,645,000 after purchasing an additional 12,493 shares in the last quarter. BNP Paribas Financial Markets lifted its stake in Encompass Health by 2.1% during the fourth quarter. BNP Paribas Financial Markets now owns 66,161 shares of the company’s stock worth $7,022,000 after purchasing an additional 1,358 shares in the last quarter. Norges Bank acquired a new position in Encompass Health during the fourth quarter worth $133,221,000. Finally, Eurizon Capital SGR S.p.A. acquired a new stake in shares of Encompass Health in the fourth quarter valued at $143,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Insider Activity

In other news, EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $104.56, for a total transaction of $71,309.92. Following the sale, the executive vice president owned 24,755 shares in the company, valued at $2,588,382.80. This trade represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.80% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

EHC has been the subject of a number of analyst reports. TD Cowen began coverage on shares of Encompass Health in a research note on Thursday, May 28th. They set a “buy” rating and a $125.00 target price for the company. Barclays decreased their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Leerink Partners set a $152.00 price objective on shares of Encompass Health in a research note on Friday, May 22nd. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, Encompass Health presently has a consensus rating of “Buy” and a consensus target price of $143.86.

Encompass Health Price Performance

Encompass Health stock opened at $101.18 on Tuesday. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The stock has a market capitalization of $10.04 billion, a P/E ratio of 16.89, a P/E/G ratio of 2.27 and a beta of 0.72. The firm’s 50-day moving average is $103.86 and its two-hundred day moving average is $104.88. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same period in the previous year, the firm earned $1.37 earnings per share. Encompass Health’s revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities analysts predict that Encompass Health Corporation will post 5.97 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.19 per share. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.8%. Encompass Health’s dividend payout ratio (DPR) is currently 12.69%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.